Livtrin-SG Softgels contain Levocetirizine 5 mg, a potent third-generation non-sedating antihistamine used primarily for the relief of allergic symptoms. Levocetirizine acts as a selective antagonist of peripheral H1 histamine receptors, effectively inhibiting the action of histamine, a key mediator in allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial forms, as well as chronic idiopathic urticaria characterized by itching and hives. Livtrin-SG Softgels provide rapid onset of action and sustained symptom control with once-daily dosing, improving patient compliance. The softgel formulation enhances bioavailability and ease of administration. Levocetirizine is generally well tolerated, with a low incidence of sedation compared to first-generation antihistamines, making it suitable for daytime use. Common adverse effects may include mild headache, dry mouth, and fatigue, though these are infrequent. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Livtrin-SG Softgels should be used under medical supervision, especially in special populations such as pregnant or lactating women. Overall, Livtrin-SG Softgels offer an effective and convenient option for managing allergic conditions with minimal side effects.